Really?; ). As I recall Specials are for therapies in Phase 3 trials which means safety has already been established. Now I may be remembering wrong or perhaps regulations have changed but that is the last I recall reading about Specials treatment criteria. Best wishes.
Market Data 
Markets 
AI
